Nurses’ Perspective on Approaches to Limit Flu-Like Symptoms During Interferon Therapy for Multiple Sclerosis

Background: Several interferon beta (IFNβ) formulations are approved for first-line use as disease-modifying therapies to treat patients with multiple sclerosis (MS). Systemic post-injection reactions, often termed flu-like symptoms (FLS), occur in approximately half of all patients treated with IFN...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Filipi, Mary L., Beavin, Jill, Brillante, Raquel T., Costello, Kathleen, Hartley, Gail C., Hartley, Kay, Namey, Marie, O'Leary, Shirley, Remington, Gina
Formato: Artigo
Idioma:Inglês
Publicado em: The Consortium of Multiple Sclerosis Centers 2014
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3967704/
https://ncbi.nlm.nih.gov/pubmed/24688355
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7224/1537-2073.2013-006
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados